Mock PLI with 6 former FDA investigators & reviewers

A mid-size cell therapy company who had just submitted their first BLA asked for a full onsite Pre License Inspection with inspectors and reviewers who had just left the agency and had extensive cell and gene therapy experience including BIMO. Their goal was to see where they stood on this first in kind therapy with unique turnaround time challenges for sterility testing as well as running the back-room audit support team and SMEs through a full inspection

PQC provided a week onsite, identifying several critical observations in aseptic processing, EM approach, data integrity, utilities, and QC methods with sufficient time to obtain a First Time Right PLI from CBER.

Ready to Turn Your Compliance Challenges into a Success Story?

Extended Industry Impact

A Comprehensive Portfolio of Global Regulatory Success

Beyond our featured case studies, PQC has successfully navigated hundreds of critical assignments across the life sciences spectrum. From Fortune 500 pharmaceutical giants to pre-clinical startups, our oversight has secured compliance for small molecule parenterals, complex biologics, and innovative medical devices. Whether resolving localized pharmacovigilance gaps or leading multi-site sterile facility startups, our history is defined by the consistent delivery of “audit-ready” excellence and operational integrity.

Mock PLI with 6 former FDA investigators & reviewers